中国当代儿科杂志2026，Vol.28Issue(5)：529-535,7.DOI:10.7499/j.issn.1008-8830.2603060
《欧洲新生儿呼吸窘迫综合征管理共识指南2025版》解读
Interpretation of the"European consensus guidelines on the management of respiratory distress syndrome:2025"
摘要
Abstract
Neonatal respiratory distress syndrome(RDS)is a critical disease caused by pulmonary surfactant(PS)deficiency,leading to respiratory distress soon after birth.Comprehensive perinatal interventions can significantly improve outcomes.The core goal of RDS management is to maximize infant survival while minimizing lung injury.Based on the latest evidence,European neonatologists and obstetricians jointly developed the"European consensus guidelines on the management of respiratory distress syndrome:2025".The guidelines provide evidence-based clinical recommendations for the management of RDS in preterm infants,covering the entire pathway from prenatal interventions,delivery room stabilization,surfactant administration,non-invasive and invasive respiratory support,to comprehensive supportive care.The aim is to reduce the incidence of lung injury through targeted interventions,increase survival rates,and improve long-term neurodevelopmental outcomes.This article interprets the 2025 guidelines in comparison with the 2022 version,aiming to improve the clinical competence of Chinese neonatologists in the diagnosis and treatment of RDS.关键词
呼吸窘迫综合征/产前皮质类固醇/无创呼吸支持/表面活性物质治疗/机械通气/早产儿Key words
Respiratory distress syndrome/Antenatal corticosteroid/Non-invasive respiratory support/Surfactant therapy/Mechanical ventilation/Preterm infant引用本文复制引用
陈筱青,David G SWEET,史源..《欧洲新生儿呼吸窘迫综合征管理共识指南2025版》解读[J].中国当代儿科杂志,2026,28(5):529-535,7.基金项目
国家重点研发计划(2022YFC2704803) （2022YFC2704803）
重庆医科大学附属儿童医院"登峰计划"临床研究项目(CHCMU-2024-XKDF-1002) （CHCMU-2024-XKDF-1002）
江苏省卫生健康委员会医学科研重点项目(K2023007). （K2023007）
